Clinical Trial

Hemodiafiltration Versus Hemodialysis in Older People

Study acronym: HD-OLDER
Recruiting
View on ClinicalTrials.gov →
Summary
This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF). Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis. These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-30; most recent amendment 2026-02-20.
Status change: Not Yet Recruiting → Recruiting 2026-02-20
Trial Details
NCT Number NCT07278973
Lead Sponsor AUB Santé
Conditions Hemodialysis, Hemodiafiltration, Fatigue Symptom, Quality of Life of Patients, Older People
Enrollment 62 participants
Start Date 2026-02-19
Primary Completion 2026-12-19 (estimated)
Study Completion 2026-12-19 (estimated)
Updated on ClinicalTrials.gov 2026-02-23